Latest On Marinus Pharmaceuticals, Inc (MRNS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-26 13:55 EST | News | Marinus' seizure drug Ztalmy inches toward EU approval with EMA nod | N/A |  |
| 2023-05-11 22:24 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-11 08:12 EST | News | Marinus Pharmaceuticals GAAP EPS of -$0.67 beats by $0.13, revenue of $10.38M beats by $5.47M | N/A | |
| 2023-03-31 23:23 EST | News | Marinus launches $375M mixed shelf offering - filing | N/A | |
| 2023-03-22 14:13 EST | News | Marinus ganaxolone for severe epilepsy gets FDA orphan drug status | N/A | |
| 2023-03-08 12:36 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-07 22:04 EST | News | Marinus Pharmaceuticals GAAP EPS of -$0.76 misses by $0.16, revenue of $7.16M misses by $1.99M | N/A | |
| 2023-03-07 07:13 EST | News | Marinus Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-01-20 20:10 EST | News | Marinus Pharmaceuticals initiated at outperform at RBC on epilepsy drug | N/A | |
| 2022-11-18 00:18 EST | News | Marinus Pharmaceuticals taps CEO Scott Braunstein as chairman | N/A | |
| 2022-11-18 00:18 EST | News | Marinus to get $10M upfront in license pact with Tenacia to develop CNS therapies in China | N/A | |
| 2022-11-08 15:51 EST | News | Marinus Pharmaceuticals shares slide 18% on $60M securities offering | N/A | |
| 2022-11-08 15:49 EST | News | Marinus Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-08 15:48 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-07 21:56 EST | News | Marinus Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-11-07 21:55 EST | News | Marinus PharmaceuticalsEPS of $1.89, revenue of $2.34M misses by $23.42M | N/A | |
| 2022-11-07 21:55 EST | News | Marinus Pharmaceuticals stock drops 19% aftermarket on proposed public offering | N/A | |
| 2022-10-31 21:13 EST | News | Marinus Pharmaceuticals enters $32.5M interest financing agreement with Sagard Healthcare Partners | N/A | |
| 2022-09-22 20:41 EST | News | US government uses contract option for Marinus' seizure therapy ganaxolone | N/A | |
| 2022-09-22 20:39 EST | News | Marinus Pharmaceuticals: Positive News Flow Of Note | N/A | |
| 2022-08-30 07:22 EST | News | Marinus Pharma closes on sale of a U.S. FDA priority review voucher for $110M | N/A | |
| 2022-08-12 05:22 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 12:40 EST | News | Marinus Pharmaceuticals GAAP EPS of -$1.06 misses by $0.37, revenue of $1.8M misses by $0.51M | N/A | |
| 2022-08-10 20:29 EST | News | Marinus Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-07-28 11:29 EST | News | Marinus Pharma announces U.S. commercial launch of seizure therapy Ztalmy | N/A | |
| 2022-07-14 08:28 EST | News | Marinus stock rises as it sells priority review voucher for $110M | N/A | |
| 2022-06-01 17:57 EST | News | Marinus granted additional time in European review of seizure candidate | N/A | |
| 2022-05-24 23:26 EST | News | Marinus Pharmaceuticals (MRNS) Investor Presentation - Slideshow | N/A | |
| 2022-05-12 20:44 EST | News | Marinus Pharmaceuticals GAAP EPS of -$0.52 beats by $0.33, revenue of $14.19M beats by $11.91M | N/A | |
| 2022-05-12 20:43 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 02:15 EST | News | Marinus Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-05-06 05:21 EST | News | Marinus stock rises premarket after resuming phase 3 RAISE trial for prolonged seizures | N/A | |
| 2022-05-06 05:21 EST | News | Revisiting Marinus Pharmaceuticals | N/A | |
| 2022-04-01 09:22 EST | News | Marinus gets $30M under Oaktree credit facility following Ztalmy US approval | N/A | |
| 2022-03-23 07:25 EST | News | Marinus Pharmaceuticals higher as Truist and JMP raises price target after FDA approved ZTALMY | N/A | |
| 2022-03-23 07:25 EST | News | Marinus Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-21 21:32 EST | News | Marinus Pharmaceuticals GAAP EPS of -$0.77 misses by $0.02, revenue of $1.52M misses by $1.98M | N/A | |
| 2022-03-21 21:31 EST | News | Marinus Pharma falls as Q4 earnings miss adds to trial delays | N/A | |
| 2022-03-21 21:31 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) CEO Dr. Scott Braunstein on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-19 01:49 EST | News | Marinus Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-03-19 01:48 EST | News | Marinus Pharma spikes on FDA approval for seizure therapy | N/A | |
| 2022-02-28 15:35 EST | News | Marinus Stock Slides To 18-Month Low, Upcoming PDUFA May Offer Redemption | N/A | |
| 2022-02-23 22:02 EST | News | Marinus slips to a 52-week low as analysts react to delays for clinical studies | N/A | |
| 2022-02-23 03:23 EST | News | Marinus falls after announcing delay for clinical programs citing Omicron impact | N/A | |
| 2021-12-03 17:35 EST | News | Data shows extended benefit of Marinus epilepsy treatment ganaxolone up to a year | N/A | |
| 2021-11-10 12:14 EST | News | Marinus Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-10 12:14 EST | News | Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-09 13:08 EST | News | Marinus Pharmaceuticals EPS beats by $0.12, beats on revenue | N/A | |
| 2021-11-08 15:27 EST | News | Marinus Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-09-22 00:52 EST | News | FDA accepts Marinus' ganaxolone NDA for review under Priority status | N/A | |
About Marinus Pharmaceuticals, Inc (MRNS):
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including intravenous (IV) and oral for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ganaxolone product candidate, acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, and postpartum depression. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
General
- Name Marinus Pharmaceuticals, Inc
- Symbol MRNS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 65
- Last Split Factor1:4
- Last Split Date2020-09-23
- Fiscal Year EndDecember
- IPO Date2014-07-31
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.marinuspharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 2513.8
- Price/Book (Most Recent Quarter) 8.42
- Enterprise Value Revenue 338.01
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.95
- Next Year EPS Estimate -$2.38
- Next Quarter EPS Estimate -$0.45
- Operating Margin -3954%
- Return on Assets -34%
- Return on Equity -60%
- Revenue 1.72 million
- Earnings Per Share -$0.98
- Revenue Per Share $0.06
- Gross Profit -25387000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 597.22 million
- EBITDA -45371000
- PE Ratio -0.57
- Analyst Target Price $29.78
- Book Value Per Share $3.63
View More
Share Statistics
- Shares Outstanding 36.58 million
- Shares Float 24.59 million
- % Held by Insiders 255%
- % Held by Institutions 71.12%
- Shares Short 4.23 million
- Shares Short Prior Month 4.18 million
- Short Ratio 14.35
- Short % of Float 12%
- Short % of Shares Outstanding 12%
View More
Technicals
- Beta 1.58
- 52 Week High $20.04
- 52 Week Low $5.92
- 50 Day Moving Average 15.09
- 200 Day Moving Average 13.48
View More
Dividends
- Dividend Date 2020-09-23
- ExDividend Date N/A
- Dividend Yield 0%
View More
Marinus Pharmaceuticals, Inc (MRNS) Dividend Calendar:
MRNS's last dividend payment was made to shareholders on September 23, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Marinus Pharmaceuticals, Inc (MRNS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-09 | $N/A | -$0.51 | -$0.50 | -1.19% |
| 2020-09-30 | 2020-11-09 | $171000 | -$0.51 | -$0.60 | 15.28% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.64 | -$0.80 | 20% |
| 2020-03-31 | 2020-05-04 | $N/A | -$1.28 | -$0.65 | -96.92% |
| 2019-12-31 | 2020-03-16 | $N/A | -$1.00 | -$0.83 | -19.86% |
| 2019-09-30 | 2019-11-06 | $N/A | -$1.04 | -$0.95 | -9.64% |
| 2019-06-30 | 2019-08-08 | $N/A | -$0.96 | -$0.95 | -1.4% |
| 2019-03-31 | 2019-05-01 | $N/A | -$0.96 | -$0.86 | -11.63% |
| 2018-12-31 | 2019-03-11 | $N/A | -$0.96 | -$1.03 | 6.34% |
| 2018-09-30 | 2018-10-29 | $N/A | -$1.08 | -$0.84 | -28.57% |
| 2018-06-30 | 2018-08-02 | $N/A | -$0.96 | -$0.62 | -54.84% |
| 2018-03-31 | 2018-05-02 | $N/A | -$0.60 | -$0.65 | 8.16% |
| 2017-12-31 | 2018-03-06 | $N/A | -$0.80 | -$0.62 | -29.03% |
| 2017-09-30 | 2017-10-31 | $N/A | -$0.60 | -$0.68 | 11.76% |
| 2017-06-30 | 2017-08-01 | $N/A | -$0.84 | -$1.08 | 22.22% |
| 2017-03-31 | 2017-05-01 | $N/A | -$1.04 | -$1.28 | 18.75% |
| 2016-12-31 | 2017-03-13 | $N/A | -$1.24 | -$1.38 | 10.14% |
| 2016-09-30 | 2016-11-03 | $N/A | -$1.32 | -$1.92 | 31.25% |
| 2016-06-30 | 2016-08-09 | $N/A | -$1.84 | -$1.53 | -20% |
| 2016-03-31 | 2016-05-02 | $N/A | -$1.48 | -$1.64 | 9.76% |
| 2015-12-31 | 2016-03-07 | $N/A | -$1.80 | -$1.18 | -52.54% |
| 2015-09-30 | 2015-10-29 | $N/A | -$0.35 | -$0.51 | 31.37% |
| 2015-06-30 | 2015-08-04 | $N/A | -$0.37 | -$0.51 | 27.45% |
| 2015-03-31 | 2015-05-11 | $N/A | -$0.50 | -$0.47 | -6.38% |
| 2014-12-31 | 2015-03-12 | $N/A | -$0.26 | -$0.39 | 33.33% |
| 2014-09-30 | 2014-11-13 | $N/A | -$0.22 | -$0.45 | 51.11% |
| 2014-06-30 | 2014-09-03 | $N/A | -$1.28 |
Marinus Pharmaceuticals, Inc (MRNS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Marinus Pharmaceuticals, Inc (MRNS) Chart:
Marinus Pharmaceuticals, Inc (MRNS) News:
Below you will find a list of latest news for Marinus Pharmaceuticals, Inc (MRNS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Marinus Pharmaceuticals, Inc (MRNS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 1 | 0.5 | CALL | 22 | 872 | 188.36 | TRUE | -0.1 | -0.17 |
| 2024-05-17 | 2 | 0.05 | CALL | 230 | 3750 | 191.59 | FALSE | 0 | 0 |
| 2024-05-17 | 3 | 0.05 | CALL | 4 | 612 | 326.46 | FALSE | 0.05 | 0 |
| 2024-05-17 | 4 | 0.3 | CALL | 0 | 432 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.05 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 6 | 0.05 | CALL | 0 | 881 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7 | 0.05 | CALL | 0 | 215 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 8 | 0.05 | CALL | 0 | 105 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 9 | 0.05 | CALL | 0 | 346 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.05 | CALL | 0 | 2290 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 11 | 0.05 | CALL | 0 | 90 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12 | 0.05 | CALL | 0 | 7539 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 13 | 0.05 | CALL | 0 | 32 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 14 | 0.03 | CALL | 0 | 125 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 1.7 | CALL | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 16 | 0.01 | CALL | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17 | 0.05 | CALL | 0 | 14 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 18 | 0.9 | CALL | 0 | 23 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0.05 | PUT | 0 | 621 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0.5 | PUT | 2 | 10842 | 448.02 | TRUE | 0.1 | 0.25 |
| 2024-05-17 | 3 | 1.45 | PUT | 3 | 699 | 661.72 | TRUE | 1.45 | 0 |
| 2024-05-17 | 4 | 2.62 | PUT | 0 | 554 | 374.7 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 3.49 | PUT | 1 | 3581 | 778.5 | TRUE | 3.49 | 0 |
| 2024-05-17 | 6 | 4.55 | PUT | 3 | 881 | 480.01 | TRUE | 4.55 | 0 |
| 2024-05-17 | 7 | 5.6 | PUT | 0 | 204 | 762.46 | TRUE | 0 | 0 |
| 2024-05-17 | 8 | 6.6 | PUT | 0 | 50 | 656.5 | TRUE | 0 | 0 |
| 2024-05-17 | 9 | 7.5 | PUT | 0 | 1 | 1258.35 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 4.2 | PUT | 0 | 0 | 1286.76 | TRUE | 0 | 0 |
| 2024-05-17 | 11 | 5.4 | PUT | 0 | 0 | 1260.48 | TRUE | 0 | 0 |
| 2024-05-17 | 12 | 5.6 | PUT | 0 | 0 | 1334.85 | TRUE | 0 | 0 |
| 2024-05-17 | 13 | 0 | PUT | 0 | 0 | 1355.59 | TRUE | 0 | 0 |
| 2024-05-17 | 14 | 0 | PUT | 0 | 0 | 1220.5 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 811.31 | TRUE | 0 | 0 |
| 2024-05-17 | 16 | 0 | PUT | 0 | 0 | 1356.9 | TRUE | 0 | 0 |
| 2024-05-17 | 17 | 0 | PUT | 0 | 0 | 841.08 | TRUE | 0 | 0 |
| 2024-05-17 | 18 | 0 | PUT | 0 | 0 | 1231.74 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 0.8 | CALL | 0 | 11 | 112.04 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 0.15 | CALL | 34 | 172 | 145.02 | FALSE | 0.05 | 0.5 |
| 2024-06-21 | 3 | 0.05 | CALL | 0 | 47 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1 | 0.05 | PUT | 2 | 12 | 123.2 | FALSE | 0.05 | 0 |
| 2024-06-21 | 2 | 0 | PUT | 0 | 0 | 113.77 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 0 | PUT | 0 | 0 | 414.42 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0 | PUT | 0 | 0 | 152.91 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 261.33 | TRUE | 0 | 0 |
| 2024-07-19 | 1 | 0.6 | CALL | 0 | 2084 | 85.26 | TRUE | 0 | 0 |
| 2024-07-19 | 2 | 0.25 | CALL | 5 | 2648 | 151.88 | FALSE | 0.05 | 0.25 |
| 2024-07-19 | 3 | 0.15 | CALL | 0 | 70 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 4 | 0.06 | CALL | 0 | 166 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0.05 | CALL | 0 | 59 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 6 | 0.1 | CALL | 0 | 210 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 7 | 4.24 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 8 | 0.1 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 9 | 0.05 | CALL | 0 | 31 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 10 | 0.1 | CALL | 2 | 2128 | 269.91 | FALSE | 0.1 | 0 |
| 2024-07-19 | 11 | 0.05 | CALL | 0 | 37 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 12 | 0.05 | CALL | 0 | 75 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 13 | 0.05 | CALL | 0 | 113 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 14 | 0.04 | CALL | 0 | 14 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 15 | 0.05 | CALL | 0 | 1659 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 16 | 1.7 | CALL | 0 | 17 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 20 | 0.05 | CALL | 0 | 463 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 1 | 0.05 | PUT | 0 | 237 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2 | 0.8 | PUT | 0 | 4 | 112.35 | TRUE | 0 | 0 |
| 2024-07-19 | 3 | 1 | PUT | 0 | 2 | 160.89 | TRUE | 0 | 0 |
| 2024-07-19 | 4 | 2.62 | PUT | 0 | 11 | 241.67 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 3.72 | PUT | 0 | 1 | 415.07 | TRUE | 0 | 0 |
| 2024-07-19 | 6 | 4.58 | PUT | 0 | 13 | 232 | TRUE | 0 | 0 |
| 2024-07-19 | 7 | 3.1 | PUT | 0 | 63 | 249.44 | TRUE | 0 | 0 |
| 2024-07-19 | 8 | 6.75 | PUT | 0 | 11 | 471.48 | TRUE | 0 | 0 |
| 2024-07-19 | 9 | 3.8 | PUT | 0 | 0 | 446.68 | TRUE | 0 | 0 |
| 2024-07-19 | 10 | 4.48 | PUT | 0 | 0 | 458.93 | TRUE | 0 | 0 |
| 2024-07-19 | 11 | 4.8 | PUT | 0 | 0 | 508.71 | TRUE | 0 | 0 |
| 2024-07-19 | 12 | 5.6 | PUT | 0 | 0 | 499.19 | TRUE | 0 | 0 |
| 2024-07-19 | 13 | 5.5 | PUT | 0 | 0 | 527.96 | TRUE | 0 | 0 |
| 2024-07-19 | 14 | 6.2 | PUT | 0 | 0 | 516.94 | TRUE | 0 | 0 |
| 2024-07-19 | 15 | 8.22 | PUT | 0 | 0 | 544.52 | TRUE | 0 | 0 |
| 2024-07-19 | 16 | 0 | PUT | 0 | 0 | 493.89 | TRUE | 0 | 0 |
| 2024-07-19 | 20 | 11.2 | PUT | 0 | 0 | 558.77 | TRUE | 0 | 0 |
| 2024-10-18 | 1 | 0.75 | CALL | 5 | 1 | 145.88 | TRUE | 0.75 | 0 |
| 2024-10-18 | 2 | 0.4 | CALL | 33 | 1450 | 137.86 | FALSE | 0.05 | 0.14 |
| 2024-10-18 | 3 | 0.29 | CALL | 0 | 20 | 152.79 | FALSE | 0 | 0 |
| 2024-10-18 | 4 | 0.14 | CALL | 0 | 78 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 5 | 0.2 | CALL | 56 | 217 | 167.1 | FALSE | 0.05 | 0.33 |
| 2024-10-18 | 6 | 0.15 | CALL | 0 | 26 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 7 | 0.1 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 8 | 0.1 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 9 | 0.05 | CALL | 0 | 10 | 437.94 | FALSE | 0 | 0 |
| 2024-10-18 | 10 | 0.05 | CALL | 11 | 556 | 155.6 | FALSE | 0.05 | 0 |
| 2024-10-18 | 11 | 2.65 | CALL | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 12 | 0.05 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 13 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 14 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 15 | 3 | CALL | 0 | 21 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 16 | 0.07 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 17 | 0.09 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 18 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 1 | 0.18 | PUT | 0 | 19 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 2 | 0.85 | PUT | 1 | 64 | 130.21 | TRUE | 0.85 | 0 |
| 2024-10-18 | 3 | 1.76 | PUT | 0 | 3 | 199.63 | TRUE | 0 | 0 |
| 2024-10-18 | 4 | 2.8 | PUT | 0 | 9 | 162.32 | TRUE | 0 | 0 |
| 2024-10-18 | 5 | 1.16 | PUT | 0 | 2 | 151.18 | TRUE | 0 | 0 |
| 2024-10-18 | 6 | 4.57 | PUT | 0 | 29 | 212.31 | TRUE | 0 | 0 |
| 2024-10-18 | 7 | 5.42 | PUT | 0 | 31 | 179.84 | TRUE | 0 | 0 |
| 2024-10-18 | 8 | 6.5 | PUT | 0 | 0 | 329.28 | TRUE | 0 | 0 |
| 2024-10-18 | 9 | 3.21 | PUT | 0 | 0 | 274.42 | TRUE | 0 | 0 |
| 2024-10-18 | 10 | 0 | PUT | 0 | 0 | 854.6 | TRUE | 0 | 0 |
| 2024-10-18 | 11 | 0 | PUT | 0 | 0 | 358.18 | TRUE | 0 | 0 |
| 2024-10-18 | 12 | 4.9 | PUT | 0 | 0 | 326.1 | TRUE | 0 | 0 |
| 2024-10-18 | 13 | 0 | PUT | 0 | 0 | 373.52 | TRUE | 0 | 0 |
| 2024-10-18 | 14 | 0 | PUT | 0 | 0 | 380.42 | TRUE | 0 | 0 |
| 2024-10-18 | 15 | 13.5 | PUT | 0 | 0 | 400.97 | TRUE | 0 | 0 |
| 2024-10-18 | 16 | 0 | PUT | 0 | 0 | 325.91 | TRUE | 0 | 0 |
| 2024-10-18 | 17 | 0 | PUT | 0 | 0 | 371.6 | TRUE | 0 | 0 |
| 2024-10-18 | 18 | 0 | PUT | 0 | 0 | 261.46 | TRUE | 0 | 0 |
Latest MRNS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 10 | $4.075 |
| Jun 13, 2022 7:59 PM EST | 10 | $4.08 |
| Jun 13, 2022 7:59 PM EST | 20 | $4.08 |
| Jun 13, 2022 7:59 PM EST | 16 | $4.08 |
| Jun 13, 2022 7:59 PM EST | 3 | $4.08 |
Marinus Pharmaceuticals, Inc (MRNS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920074237/0001104659-20-074237-index.htm |
| 2020-05-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1267813/000000000020003918/0000000000-20-003918-index.htm |
| 2020-07-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1267813/000000000020006484/0000000000-20-006484-index.htm |
| 2018-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000003877718000006/0000038777-18-000006-index.htm |
| 2019-03-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000003877719000103/0000038777-19-000103-index.htm |
| 2018-02-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000005341718000041/0000053417-18-000041-index.htm |
| 2019-02-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000005341719000039/0000053417-19-000039-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000005341720000047/0000053417-20-000047-index.htm |
| 2017-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm |
| 2018-01-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000090266418000144/0000902664-18-000144-index.htm |
| 2019-01-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000090266419000380/0000902664-19-000380-index.htm |
| 2019-12-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000090266419004643/0000902664-19-004643-index.htm |
| 2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000090266420000490/0000902664-20-000490-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000090266420001117/0000902664-20-001117-index.htm |
| 2017-12-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000090445417000712/0000904454-17-000712-index.htm |
| 2018-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000090445418000049/0000904454-18-000049-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000090445419000270/0000904454-19-000270-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000090445420000030/0000904454-20-000030-index.htm |
| 2020-09-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1267813/000090445420000638/0000904454-20-000638-index.htm |
| 2020-11-06 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000090445420000703/0000904454-20-000703-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000093583618000131/0000935836-18-000131-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000101359420000175/0001013594-20-000175-index.htm |
| 2018-12-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000104746918007592/0001047469-18-007592-index.htm |
| 2018-12-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000104746918007641/0001047469-18-007641-index.htm |
| 2019-12-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000104746919006783/0001047469-19-006783-index.htm |
| 2019-12-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000104746919006827/0001047469-19-006827-index.htm |
| 2020-05-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000104746920003242/0001047469-20-003242-index.htm |
| 2020-05-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000104746920003267/0001047469-20-003267-index.htm |
| 2017-12-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465917072520/0001104659-17-072520-index.htm |
| 2017-12-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465917072522/0001104659-17-072522-index.htm |
| 2018-01-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918003364/0001104659-18-003364-index.htm |
| 2018-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918003365/0001104659-18-003365-index.htm |
| 2018-01-22 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918003367/0001104659-18-003367-index.htm |
| 2018-01-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004809/0001104659-18-004809-index.htm |
| 2018-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004810/0001104659-18-004810-index.htm |
| 2018-01-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004812/0001104659-18-004812-index.htm |
| 2018-01-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004813/0001104659-18-004813-index.htm |
| 2018-01-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004814/0001104659-18-004814-index.htm |
| 2018-01-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004815/0001104659-18-004815-index.htm |
| 2018-01-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004816/0001104659-18-004816-index.htm |
| 2018-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465918025843/0001104659-18-025843-index.htm |
| 2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465918055332/0001104659-18-055332-index.htm |
| 2018-09-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465918057807/0001104659-18-057807-index.htm |
| 2018-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465918071355/0001104659-18-071355-index.htm |
| 2018-12-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465918071840/0001104659-18-071840-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465918071971/0001104659-18-071971-index.htm |
| 2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465918073125/0001104659-18-073125-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919004457/0001104659-19-004457-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919004459/0001104659-19-004459-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011608/0001104659-19-011608-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011635/0001104659-19-011635-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011636/0001104659-19-011636-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011637/0001104659-19-011637-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011638/0001104659-19-011638-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011639/0001104659-19-011639-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011640/0001104659-19-011640-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919011641/0001104659-19-011641-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919014829/0001104659-19-014829-index.htm |
| 2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919016324/0001104659-19-016324-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919016364/0001104659-19-016364-index.htm |
| 2019-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919027184/0001104659-19-027184-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919027802/0001104659-19-027802-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919030563/0001104659-19-030563-index.htm |
| 2019-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919041464/0001104659-19-041464-index.htm |
| 2019-08-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1267813/000110465919044907/0001104659-19-044907-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919044912/0001104659-19-044912-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919044913/0001104659-19-044913-index.htm |
| 2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919047142/0001104659-19-047142-index.htm |
| 2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919047144/0001104659-19-047144-index.htm |
| 2019-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919051485/0001104659-19-051485-index.htm |
| 2019-10-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000110465919053242/0001104659-19-053242-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919055267/0001104659-19-055267-index.htm |
| 2019-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919057204/0001104659-19-057204-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919061665/0001104659-19-061665-index.htm |
| 2019-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919063472/0001104659-19-063472-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919070786/0001104659-19-070786-index.htm |
| 2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919071737/0001104659-19-071737-index.htm |
| 2019-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919072272/0001104659-19-072272-index.htm |
| 2019-12-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919072560/0001104659-19-072560-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919072570/0001104659-19-072570-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919072572/0001104659-19-072572-index.htm |
| 2019-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465919072574/0001104659-19-072574-index.htm |
| 2019-12-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465919073914/0001104659-19-073914-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003094/0001104659-20-003094-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003095/0001104659-20-003095-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003097/0001104659-20-003097-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003098/0001104659-20-003098-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003099/0001104659-20-003099-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003100/0001104659-20-003100-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920003102/0001104659-20-003102-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920009947/0001104659-20-009947-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000110465920021720/0001104659-20-021720-index.htm |
| 2020-02-20 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1267813/000110465920023425/0001104659-20-023425-index.htm |
| 2020-03-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267813/000110465920027545/0001104659-20-027545-index.htm |
| 2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920037409/0001104659-20-037409-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920042426/0001104659-20-042426-index.htm |
| 2020-04-29 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1267813/000110465920053331/0001104659-20-053331-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920055872/0001104659-20-055872-index.htm |
| 2020-05-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1267813/000110465920059524/0001104659-20-059524-index.htm |
| 2020-05-11 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1267813/000110465920059534/0001104659-20-059534-index.htm |
| 2020-05-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1267813/000110465920060846/0001104659-20-060846-index.htm |
| 2020-05-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267813/000110465920063156/0001104659-20-063156-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920066366/0001104659-20-066366-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920067778/0001104659-20-067778-index.htm |
| 2020-06-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920074162/0001104659-20-074162-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920074168/0001104659-20-074168-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920074237/0001104659-20-074237-index.htm |
| 2020-07-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1267813/000110465920082429/0001104659-20-082429-index.htm |
| 2020-07-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1267813/000110465920082467/0001104659-20-082467-index.htm |
| 2020-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920082491/0001104659-20-082491-index.htm |
| 2020-07-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1267813/000110465920084038/0001104659-20-084038-index.htm |
| 2020-07-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1267813/000110465920084948/0001104659-20-084948-index.htm |
| 2020-07-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1267813/000110465920086497/0001104659-20-086497-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920087919/0001104659-20-087919-index.htm |
| 2020-08-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920090463/0001104659-20-090463-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267813/000110465920090464/0001104659-20-090464-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920093891/0001104659-20-093891-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920104612/0001104659-20-104612-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920104915/0001104659-20-104915-index.htm |
| 2020-09-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000110465920107215/0001104659-20-107215-index.htm |
| 2018-01-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000113777418000009/0001137774-18-000009-index.htm |
| 2019-02-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000113777419000032/0001137774-19-000032-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000113777420000056/0001137774-20-000056-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000117891318000508/0001178913-18-000508-index.htm |
| 2017-12-19 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000119312517373740/0001193125-17-373740-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000119312519039756/0001193125-19-039756-index.htm |
| 2019-12-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000119312519314029/0001193125-19-314029-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000119312520036502/0001193125-20-036502-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267813/000119380518000226/0001193805-18-000226-index.htm |
| 2018-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1267813/000155837018001587/0001558370-18-001587-index.htm |
| 2018-03-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267813/000155837018001591/0001558370-18-001591-index.htm |
| 2018-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000155837018001594/0001558370-18-001594-index.htm |
| 2018-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837018003708/0001558370-18-003708-index.htm |
| 2018-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000155837018003710/0001558370-18-003710-index.htm |
| 2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000155837018006262/0001558370-18-006262-index.htm |
| 2018-08-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837018006266/0001558370-18-006266-index.htm |
| 2018-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837018007973/0001558370-18-007973-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267813/000155837018008053/0001558370-18-008053-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1267813/000155837019001860/0001558370-19-001860-index.htm |
| 2019-03-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267813/000155837019002404/0001558370-19-002404-index.htm |
| 2019-03-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1267813/000155837019002439/0001558370-19-002439-index.htm |
| 2019-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837019003737/0001558370-19-003737-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837019007686/0001558370-19-007686-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837019010151/0001558370-19-010151-index.htm |
| 2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1267813/000155837020002792/0001558370-20-002792-index.htm |
| 2020-04-17 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1267813/000155837020003995/0001558370-20-003995-index.htm |
| 2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267813/000155837020004375/0001558370-20-004375-index.htm |
| 2020-05-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837020004979/0001558370-20-004979-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267813/000155837020009720/0001558370-20-009720-index.htm |
| 2020-05-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1267813/999999999520001162/9999999995-20-001162-index.htm |
| 2020-07-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1267813/999999999520001928/9999999995-20-001928-index.htm |
Marinus Pharmaceuticals, Inc (MRNS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Marinus Pharmaceuticals, Inc (MRNS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 255%Institutional Ownership: 7112%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 | Scott Braunstein | Chief Executive Officer | Buy | 100,000.00 | 1.25 | 125,000.00 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465919072572/0001104659-19-072572-index.htm |
| 2020-01-30 | Edward F Smith | CFO | Sell | 2,380.00 | 2.05 | 4,879.00 | 17,717.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465920009947/0001104659-20-009947-index.htm |
| 2019-05-16 | Edward F Smith | CFO | Sell | 24,211.00 | 5.03 | 121,781.33 | 20,097.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465919030563/0001104659-19-030563-index.htm |
| 2019-01-28 | Christopher Michael Cashman | CEO | Sell | 8,142.00 | 3.13 | 25,484.46 | 239,761.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465919004459/0001104659-19-004459-index.htm |
| 2018-01-18 | Christopher Michael Cashman | CEO | Sell | 9,566.00 | 6.28 | 60,074.48 | 247,903.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465918003365/0001104659-18-003365-index.htm |
| 2019-03-18 | Christopher Michael Cashman | CEO | Buy | 31,662.00 | 1.04 | 32,928.48 | 271,423.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465919016364/0001104659-19-016364-index.htm |
| 2017-12-19 | Bain Capital Life Sciences Investors, LLC | 10% Share Holder | Sell | 55,229.00 | 7.11 | 392,429.66 | 3,977,453.00 | https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm |
| 2017-12-19 | Bain Capital Life Sciences Investors, LLC | 10% Share Holder | Sell | 94,771.00 | 7.62 | 722,240.31 | 4,032,682.00 | https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm |
| 2017-12-18 | Bain Capital Life Sciences Investors, LLC | 10% Share Holder | Sell | 300,000.00 | 7.50 | 2,251,440.00 | 4,127,453.00 | https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm |
| 2017-12-15 | Bain Capital Life Sciences Investors, LLC | 10% Share Holder | Sell | 102,882.00 | 8.64 | 888,488.95 | 4,427,453.00 | https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm |
| 2019-01-29 | Edward F Smith | CFO | Sell | 2,492.00 | 3.06 | 7,625.52 | 44,308.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465919004457/0001104659-19-004457-index.htm |
| 2017-12-15 | Bain Capital Life Sciences Investors, LLC | 10% Share Holder | Sell | 719,665.00 | 8.02 | 5,770,202.00 | 4,530,335.00 | https://www.sec.gov/Archives/edgar/data/1267813/000089924317029256/0000899243-17-029256-index.htm |
| 2018-01-29 | Edward F Smith | CFO | Sell | 3,000.00 | 7.91 | 23,730.00 | 49,800.00 | https://www.sec.gov/Archives/edgar/data/1267813/000110465918004810/0001104659-18-004810-index.htm |